✦ LIBER ✦

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

✍ Scribed by Kiyofumi Yamada; Toshitaka Nabeshima

Book ID: 114129176
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 357 KB
Volume: 88
Category: Article
ISSN: 0163-7258
DOI: 10.1016/s0163-7258(00)00081-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Animal models for Alzheimer's disease an

Animal models for Alzheimer's disease and frontotemporal dementia

✍ Jurgen Gotz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Animal models of Alzheimer's disease and

Animal models of Alzheimer's disease and drug development

✍ Laurijssens, Bart; Aujard, Fabienne; Rahman, Anisur 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Animal models of Alzheimer's disease

✍ Linda Slanec Higgins 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Anti-Dementia Drugs and Co-Medication Am

Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s Disease

✍ Fereshtehnejad, Seyed-Mohammad; Johnell, Kristina; Eriksdotter, Maria 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 310 KB

Cholinergic Modulation of Amyloid Proces

Cholinergic Modulation of Amyloid Processing and Dementia in Animal Models of Alzheimer's Disease

✍ O. ISACSON; L. LIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Measuring the effects of anti-dementia d

Measuring the effects of anti-dementia drugs in patients with Alzheimer's disease

✍ S. Curran; J. P. Wattis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

A large number of experimental compounds are being developed for the treatment of patients with Alzheimer's disease (AD). As dierent compounds may have dierent eects on CNS function, depending on which neurotransmitters they aect, adequate pro®ling will require the use of several tests. The dicultie